Scottish Medicines Consortium accepts Prostap SR DCS & Prostap 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer

8 February 2021 - Takeda is pleased to announce that the Scottish Medicines Consortium has accepted Prostap SR DCS & ...

Read more →

Scottish approval of a new treatment for people with chronic obstructive pulmonary disease - formoterol fumarate dihydrate/glycopyrronium bromide/budesonide

8 February 2021 - AstraZeneca today announced that Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) is now accepted for use by the SMC ...

Read more →

SMC issues positive decision for treatment with AbbVie’s Rinvoq (upadacitinib) in severe active rheumatoid arthritis

9 February 2021 - Positive indication means upadacitinib will be available to those with previously treated severe active rheumatoid arthritis. ...

Read more →

Scotland approves MS drug that was rejected in England and Wales

9 February 2021 - A drug that can reduce the number of relapses suffered by people with multiple sclerosis has been ...

Read more →

SMC - February 2021 decisions

8 February 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

Scottish Health Technologies Group: enhancing patient engagement

20 January 2021 - The Scottish Health Technologies Group provides evidence support and advice to the National Health Service in Scotland ...

Read more →

Scotland backs Roche’s Rozlytrek for ROS1 lung cancer

19 January 2021 - The Scottish Medicines Consortium has given a green light to Roche’s Rozlytrek for a rare form ...

Read more →

SMC - January 2021 decisions

18 January 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

SMC to support innovative new medicines pathway

29 December 2020 - Experts from the Scottish Medicines Consortium are to support a new licensing and access pathway which ...

Read more →

SMC - December 2020 decisions

7 December 2020 - Medicines which can be used to treat a form of blood cancer and a rare muscle ...

Read more →

After NICE okay, Scots denied access to Vifor’s Veltassa

10 November 2020 - The SMC has ruled that there’s not enough evidence to support NHS funding of Vifor Pharma’s ...

Read more →

New osteoporosis drug for women approved for use on NHS in Scotland

9 October 2020 - A new drug to treat women with severe cases of the bone disease osteoporosis has been ...

Read more →

SMC - November 2020 decisions

9 November 2020 - Advice on eight new medicines for use in conditions including breast cancer, lung cancer and osteoporosis has ...

Read more →

Scotland backs two myeloma drugs turned down by NICE in England

14 October 2020 - A north-south divide threatens to emerge in multiple myeloma in the UK, after the Scottish Medicines ...

Read more →

SMC accepts Bavencio (avelumab) in combination with axitinib for the first-line treatment of adult patients with advanced or metastatic renal cell carcinoma

12 October 2020 - Merck and Pfizer announced today that the Scottish Medicines Consortium has accepted the immunotherapy Bavencio (avelumab) for ...

Read more →